Companies with late-stage biologics
166 companies hold rights to 231 biologics (antibodies, antibody fragments, multispecific antibodies, antibody-drug conjugates, other antibody scaffolds and therapeutic proteins) that are in Phase 3, Phase 2/3 or filed for approval. Sorted by the number of such drugs, then by name. Approved drugs are not counted. The full directory, with financials, is on the companies page.
| Company | Ticker | Late-stage | Drugs (stage, indications) |
|---|---|---|---|
| Jiangsu Hengrui Pharmaceuticals | 600276 | 12 | Adebrelimab (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer); Camrelizumab (Phase 3, Non-Small Cell Lung Cancer, Cervical Cancer, Hepatocellular Carcinoma and more); Felcorekibart (Phase 3, Atopic Dermatitis, Chronic Obstructive Pulmonary Disease, Asthma); Notiretatug rezetecan (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Cervical Cancer and more); Recaticimab (Phase 3, Atherosclerotic Cardiovascular Disease); Retlirafusp alfa (Phase 3, Non-Small Cell Lung Cancer, Gastric Cancer); Ruzaltatug rezetecan (Phase 3, Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer with EGFR Mutations); SHR-1819 (Phase 3, Atopic Dermatitis); SHR-1918 (Phase 3, Homozygous Familial Hypercholesterolemia); SHR-A1912 (Phase 3, Diffuse Large B-Cell Lymphoma); Trastuzumab rezetecan (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Ovarian Cancer and more); vunakizumab (Phase 3, Psoriatic Arthritis, Psoriasis) |
| AstraZeneca | AZN | 10 | Anselamimab (Phase 3, AL Amyloidosis); Cliramitug (Phase 3, Transthyretin Amyloidosis with Cardiomyopathy); Gefurulimab (Phase 3, Generalized Myasthenia Gravis); Puxitatug samrotecan (Phase 3, Non-Small Cell Lung Cancer, Endometrial Cancer); Rilvegostomig (Phase 3, Non-Small Cell Lung Cancer, Hepatocellular Carcinoma, Biliary Tract Cancer and more); Sonesitatug vedotin (Phase 3, Gastric Cancer); Surovatamig (Phase 3, Systemic Lupus Erythematosus, Rheumatoid Arthritis, Follicular Lymphoma and more); Torvutatug samrotecan (Phase 3, Ovarian Cancer); tozorakimab (Phase 3, Chronic Obstructive Pulmonary Disease, Asthma); Volrustomig (Phase 3, Non-Small Cell Lung Cancer, Cervical Cancer, Head and Neck Squamous Cell Carcinoma) |
| Pfizer | PFE | 8 | afimkibart (Phase 3, Ulcerative Colitis, Crohn's Disease, Atopic Dermatitis and more); Disitamab Vedotin (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, HER2-Positive Breast Cancer and more); Fetrastobart vedotin (Phase 3, Non-Small Cell Lung Cancer); PF-06823859 (Phase 3, Dermatomyositis); PF-08634404 (Phase 3, Non-Small Cell Lung Cancer, Colorectal Cancer, Endometrial Cancer); Sugemalimab (Phase 3, Non-Small Cell Lung Cancer); tilrekimig (Phase 3, Atopic Dermatitis, Chronic Obstructive Pulmonary Disease, Asthma); Sasanlimab (Phase 2/3, Non-Small Cell Lung Cancer) |
| Roche | RHHBY | 8 | afimkibart (Phase 3, Ulcerative Colitis, Crohn's Disease, Atopic Dermatitis and more); astegolimab (Phase 3, Chronic Obstructive Pulmonary Disease); Cevostamab (Phase 3, Multiple Myeloma, Systemic Lupus Erythematosus); Pegozafermin (Phase 3, MASH / NASH, Severe Hypertriglyceridemia); Prasinezumab (Phase 3, Parkinson's Disease); Tambotatug pelitecan (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma and more); Trontinemab (Phase 3, Alzheimer's Disease); Vamikibart (Phase 3, Uveitic Macular Edema) |
| AbbVie | ABBV | 7 | ABBV-706 (Phase 3, Small Cell Lung Cancer); Etentamig (Phase 3, Multiple Myeloma, AL Amyloidosis); lutikizumab (Phase 3, Atopic Dermatitis, Rheumatoid Arthritis, Hidradenitis Suppurativa); RC148 (Phase 3, Non-Small Cell Lung Cancer); Telisotuzumab Adizutecan (Phase 3, Non-Small Cell Lung Cancer, Colorectal Cancer, Advanced Metastatic Colorectal Cancer); Budigalimab (Phase 2/3, Non-Small Cell Lung Cancer, Urothelial Carcinoma); Pivekimab Sunirine (Phase 2/3, Acute Myeloid Leukemia) |
| Biocad | — | 7 | Acellbia (Phase 3, Rheumatoid Arthritis); BCD-264 (Phase 3, Multiple Myeloma); BCD-281 (Phase 3, Multiple Sclerosis); Divozilimab (Phase 3, Systemic Lupus Erythematosus, Multiple Sclerosis, Systemic Sclerosis); Levilimab (Phase 3, Rheumatoid Arthritis, COVID-19); netakimab (Phase 3, Psoriatic Arthritis, Psoriasis); Torutamig (Phase 3, Multiple Myeloma) |
| Merck & Co. | MRK | 7 | Gocatamig (Phase 3, Small Cell Lung Cancer); Ifinatamab Deruxtecan (Phase 3, Non-Small Cell Lung Cancer, Metastatic Castration-Resistant Prostate Cancer, Small Cell Lung Cancer and more); Patritumab Deruxtecan (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Breast Cancer); Raludotatug Deruxtecan (Phase 3, Non-Small Cell Lung Cancer, Ovarian Cancer); Sacituzumab Tirumotecan (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Ovarian Cancer and more); tulisokibart (Phase 3, Ulcerative Colitis, Crohn's Disease, Hidradenitis Suppurativa and more); Zilovertamab vedotin (Phase 2/3, Diffuse Large B-Cell Lymphoma) |
| Qilu Pharmaceutical | — | 7 | Iparomlimab (QL1604) (Phase 3); Iparomlimab and tuvonralimab (Phase 3, Non-Small Cell Lung Cancer, Metastatic Colorectal Cancer); QL2106 (Phase 3, Psoriasis); QL2108 (Phase 3, Atopic Dermatitis); QL2109 (Phase 3, Multiple Myeloma); QLS32015 (Phase 3, Multiple Myeloma); QLS4131 (Phase 3, Multiple Myeloma) |
| Shanghai Henlius Biotech | 2696 | 7 | HLX01 (Phase 3, Rheumatoid Arthritis); HLX04 (Phase 3, Non-Small Cell Lung Cancer, Colorectal Cancer); HLX04-O (Phase 3, Age-Related Macular Degeneration); HLX15 (Phase 3, Multiple Myeloma); Serplulimab (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Gastric Cancer); HLX43 (Phase 2/3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer); Pimurutamab (Phase 2/3, Non-Small Cell Lung Cancer) |
| Akeso | 9926 | 6 | Cadonilimab (Phase 3, Non-Small Cell Lung Cancer, Cervical Cancer, Hepatocellular Carcinoma); Ebdarokimab (Phase 3, Psoriasis); Ebronucimab (Phase 3, Atherosclerotic Cardiovascular Disease, Mixed Hyperlipidemia); Gumokimab (Phase 3, Psoriasis); Ivonescimab (Phase 3, Non-Small Cell Lung Cancer, Biliary Tract Cancer, Metastatic Colorectal Cancer); Manfidokimab (Phase 3, Atopic Dermatitis) |
| Innovent Biologics | 1801 | 6 | IBI3003 (Phase 3, Multiple Myeloma); IBI305 (Phase 3, Non-Small Cell Lung Cancer, Colorectal Cancer); IBI363 (Phase 3, Non-Small Cell Lung Cancer, Colorectal Cancer); picankibart (Phase 3, Ulcerative Colitis, Psoriasis); Sintilimab (Phase 3, Non-Small Cell Lung Cancer); Tafolecimab (Phase 3, Atherosclerotic Cardiovascular Disease) |
| Regeneron Pharmaceuticals | REGN | 6 | Cenvacibart (Phase 3, Venous Thromboembolism); Fianlimab (Phase 3, Melanoma); Freneslerbart/mevonlerbart (Phase 3, Asthma, Allergic Conjunctivitis, Cat Allergy); mibavademab (Phase 3, Obesity, Generalized Lipodystrophy); Odronextamab (Phase 3, Systemic Lupus Erythematosus, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma and more); Pozelimab (Phase 3, Age-Related Macular Degeneration, Paroxysmal Nocturnal Hemoglobinuria, Generalized Myasthenia Gravis) |
| BioNTech | BNTX | 4 | Beruzatatug pelitecan (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer); Elfetabart drozuntecan (Phase 3, Non-Small Cell Lung Cancer, Metastatic Castration-Resistant Prostate Cancer); Pumitamig (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer); Trastuzumab pamirtecan (Phase 3, HR+/HER2- Metastatic Breast Cancer, HER2-Positive Breast Cancer, Endometrial Cancer) |
| Bristol-Myers Squibb | BMY | 4 | Atigotatug (Phase 3, Small Cell Lung Cancer); Izalontamab brengitecan (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Ovarian Cancer and more); Obexelimab (Phase 3, Systemic Lupus Erythematosus, IgG4-Related Disease); Pumitamig (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer) |
| Daiichi Sankyo | 4568 | 4 | Denosumab (Xgeva) (Phase 3, Non-Small Cell Lung Cancer, Multiple Myeloma, HR+/HER2- Metastatic Breast Cancer); Ifinatamab Deruxtecan (Phase 3, Non-Small Cell Lung Cancer, Metastatic Castration-Resistant Prostate Cancer, Small Cell Lung Cancer and more); Patritumab Deruxtecan (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Breast Cancer); Raludotatug Deruxtecan (Phase 3, Non-Small Cell Lung Cancer, Ovarian Cancer) |
| Keymed Biosciences | 2162 | 4 | Gamgertamig (CM336) (Phase 3, Multiple Myeloma); Lumrotatug (Phase 3, Multiple Myeloma); Ocankitug (Phase 3, Chronic Obstructive Pulmonary Disease, Asthma); stapokibart (Phase 3, Atopic Dermatitis, Chronic Obstructive Pulmonary Disease, Asthma and more) |
| RemeGen Co., Ltd. | 688331 | 4 | Disitamab Vedotin (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, HER2-Positive Breast Cancer and more); RC148 (Phase 3, Non-Small Cell Lung Cancer); RC28-E (Phase 3, Age-Related Macular Degeneration, Diabetic Macular Edema); Telitacicept (Phase 3, Rheumatoid Arthritis, IgA Nephropathy, Sjögren's Disease and more) |
| Sanofi | SNY | 4 | duvakitug (Phase 3, Ulcerative Colitis, Crohn's Disease, Hidradenitis Suppurativa); Frexalimab (Phase 3, Systemic Lupus Erythematosus, Multiple Sclerosis); lunsekimig (Phase 3, Atopic Dermatitis, Chronic Obstructive Pulmonary Disease, Asthma); Riliprubart (Phase 3, Chronic Inflammatory Demyelinating Polyneuropathy) |
| Amgen | AMGN | 3 | Abp 234 (Phase 3, Non-Small Cell Lung Cancer); ABP 692 (Phase 3, Multiple Sclerosis); Denosumab (Xgeva) (Phase 3, Non-Small Cell Lung Cancer, Multiple Myeloma, HR+/HER2- Metastatic Breast Cancer) |
| Celltrion | 068270 | 3 | CT-P44 (Phase 3, Multiple Myeloma); CT-P51 (Phase 3, Non-Small Cell Lung Cancer); CT-P53 (Phase 3, Multiple Sclerosis) |
| Gilead Sciences | GILD | 3 | Gamgertamig (CM336) (Phase 3, Multiple Myeloma); Teropavimab (Phase 3, HIV); Zinlirvimab (Phase 3, HIV) |
| GlaxoSmithKline | GSK | 3 | Efimosfermin alfa (Phase 3, MASH / NASH); Felcorekibart (Phase 3, Atopic Dermatitis, Chronic Obstructive Pulmonary Disease, Asthma); Risvutatug rezetecan (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Esophageal Squamous Cell Carcinoma) |
| Johnson & Johnson | JNJ | 3 | Cetrelimab (Phase 3, Non-Small Cell Lung Cancer, Bladder Cancer); Pasritamig (Phase 3, Metastatic Castration-Resistant Prostate Cancer); Ramantamig (Phase 3, Multiple Myeloma) |
| Kodiak Sciences Inc. | KOD | 3 | Tabirafusp alfa (Phase 3); Tabirafusp tedromer (Phase 3, Age-Related Macular Degeneration, Diabetic Macular Edema); Tarcocimab tedromer (Phase 3, Age-Related Macular Degeneration, Wet Age-Related Macular Degeneration) |
| Shanghai Junshi Bioscience | 1877 | 3 | JS207 (Phase 3, Non-Small Cell Lung Cancer, Hepatocellular Carcinoma, Breast Cancer); Ongericimab (Phase 3, Atherosclerotic Cardiovascular Disease); Roconkibart (Phase 3, Psoriasis) |
| Sichuan Baili Pharmaceutical | 688506 | 3 | Izalontamab (Phase 3, Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma); Izalontamab brengitecan (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Ovarian Cancer and more); Trastuzumab brengitecan (Phase 3, Non-Small Cell Lung Cancer, Ovarian Cancer, Colorectal Cancer and more) |
| Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 6990 | 3 | Sacituzumab Tirumotecan (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Ovarian Cancer and more); Tagitanlimab (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Nasopharyngeal Carcinoma); WIN378 (Phase 2/3, Chronic Obstructive Pulmonary Disease, Asthma) |
| Simcere Pharmaceutical | 2096 | 3 | Endostar (Phase 3, Non-Small Cell Lung Cancer); Envafolimab (Phase 3, HIV, Non-Small Cell Lung Cancer, Chronic Hepatitis B and more); Rademikibart (Phase 3, Atopic Dermatitis, Chronic Obstructive Pulmonary Disease, Asthma) |
| Sinocelltech Group Ltd. | 688520 | 3 | SCTB14 (Phase 3, Non-Small Cell Lung Cancer); SCTC21C (Phase 3, Multiple Myeloma, Systemic Lupus Erythematosus, IgA Nephropathy and more); SCTB41 (Phase 2/3, Non-Small Cell Lung Cancer) |
| Alphamab Oncology | 9966 | 2 | Anbenitamab repodatecan (Phase 3, HR+/HER2- Metastatic Breast Cancer, Colorectal Cancer, HER2-Positive Breast Cancer); Erfonrilimab (Phase 3, Non-Small Cell Lung Cancer) |
| Annexon, Inc. | ANNX | 2 | tanruprubart (Phase 3, Huntington's Disease, Guillain-Barré Syndrome); Vonaprument (Phase 3, Age-Related Macular Degeneration, Geographic Atrophy) |
| Bio-Thera Solutions | 688177 | 2 | BAT3306 (Phase 3, Non-Small Cell Lung Cancer); BAT5906 (Phase 3, Age-Related Macular Degeneration) |
| Biogen | BIIB | 2 | Felzartamab (Phase 3, Multiple Myeloma, IgA Nephropathy, Primary Membranous Nephropathy); Litifilimab (Phase 3, Systemic Lupus Erythematosus) |
| Biohaven | BHVN | 2 | BHV-1400 (Phase 3, Chronic Kidney Disease); taldefgrobep alfa (Phase 3, Obesity, Spinal Muscular Atrophy) |
| CSPC Pharmaceutical Group | 1093 | 2 | Anbenitamab repodatecan (Phase 3, HR+/HER2- Metastatic Breast Cancer, Colorectal Cancer, HER2-Positive Breast Cancer); Efmedaglutide alfa (Phase 3, Obesity, Type 2 Diabetes) |
| CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | — | 2 | Enlonstobart (Phase 3, Non-Small Cell Lung Cancer, Cervical Cancer); stapokibart (Phase 3, Atopic Dermatitis, Chronic Obstructive Pulmonary Disease, Asthma and more) |
| DualityBio Inc. | 9606 | 2 | Elfetabart drozuntecan (Phase 3, Non-Small Cell Lung Cancer, Metastatic Castration-Resistant Prostate Cancer); Trastuzumab pamirtecan (Phase 3, HR+/HER2- Metastatic Breast Cancer, HER2-Positive Breast Cancer, Endometrial Cancer) |
| Eisai | 4523 | 2 | Serplulimab (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Gastric Cancer); Etalanetug (Phase 2/3, Alzheimer's Disease) |
| Eli Lilly | LLY | 2 | Remternetug (Phase 3, Alzheimer's Disease); Sofetabart mipitecan (Phase 3, Non-Small Cell Lung Cancer, Ovarian Cancer) |
| Everest Medicines (Beijing) Co., Ltd. | 1952 | 2 | Lerodalcibep (Phase 3, Atherosclerotic Cardiovascular Disease); Obinutuzumab beta (Bejescin) (Phase 3, Systemic Lupus Erythematosus, Follicular Lymphoma, Primary Membranous Nephropathy) |
| Genrix Bio | 688443 | 2 | Telikibart (Phase 3, Atopic Dermatitis); Velinotamig (GR1803) (Phase 3, Multiple Myeloma) |
| Glenmark Pharmaceuticals Ltd. | GLENMARK | 2 | Envafolimab (Phase 3, HIV, Non-Small Cell Lung Cancer, Chronic Hepatitis B and more); Trastuzumab rezetecan (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Ovarian Cancer and more) |
| Hangzhou Sumgen Biotech Co., Ltd. | — | 2 | Enlonstobart (Phase 3, Non-Small Cell Lung Cancer, Cervical Cancer); Sanritatug (Phase 3, Multiple Myeloma, Systemic Lupus Erythematosus) |
| Hansoh Pharmaceutical Group | 3692 | 2 | HS-20137 (Phase 3, Psoriasis); Risvutatug rezetecan (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Esophageal Squamous Cell Carcinoma) |
| Huabo Biopharm Co. | — | 2 | HB0017 (Phase 3, Psoriasis); Sotiburafusp alfa (Phase 3, Non-Small Cell Lung Cancer, Endometrial Cancer) |
| Incyte | INCY | 2 | INCA033989 (Phase 3, Essential Thrombocythemia); INCA33890 (Phase 3, Non-Small Cell Lung Cancer, Colorectal Cancer) |
| Intas Pharmaceuticals | — | 2 | HD204 (Phase 3, Non-Small Cell Lung Cancer); Serplulimab (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Gastric Cancer) |
| Laboratorio Elea Phoenix S.A. | — | 2 | MB12 (Phase 3, Non-Small Cell Lung Cancer); Racotumomab (Phase 3, Non-Small Cell Lung Cancer) |
| Mabwell Bioscience | 688062 | 2 | 7MW3711 (Phase 3, Non-Small Cell Lung Cancer); MW02 (Phase 2/3, Age-Related Macular Degeneration) |
| MediLink Therapeutics (Suzhou) Co., Ltd. | — | 2 | Beruzatatug pelitecan (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer); Tambotatug pelitecan (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma and more) |
| MedImmune LLC | — | 2 | Monalizumab (Phase 3, Non-Small Cell Lung Cancer); Oleclumab (Phase 3, Non-Small Cell Lung Cancer) |
| Novartis | NVS | 2 | VAY736 (Phase 3, Sjögren's Disease); Zigakibart (Phase 3, Chronic Kidney Disease, IgA Nephropathy) |
| Novo Nordisk | NVO | 2 | Coramitug (Phase 3, Heart Failure); Ziltivekimab (Phase 3, Atherosclerotic Cardiovascular Disease) |
| Seagen | — | 2 | Fetrastobart vedotin (Phase 3, Non-Small Cell Lung Cancer); Sigvotatug Vedotin (Phase 3, Non-Small Cell Lung Cancer) |
| Shanghai JMT-Bio | — | 2 | Becotatug (Phase 3, Non-Small Cell Lung Cancer, Colorectal Cancer); Ocankitug (Phase 3, Chronic Obstructive Pulmonary Disease, Asthma) |
| Shenyang Sunshine Pharmaceutical | — | 2 | Loncipoetin alfa (NuPIAO) (Phase 3, Chronic Kidney Disease); PF-08634404 (Phase 3, Non-Small Cell Lung Cancer, Colorectal Cancer, Endometrial Cancer) |
| Sunshine Guojian Pharmaceutical | 688336 | 2 | Amdokitug (Yisaituo) (Phase 3, Psoriasis); SSGJ-611 (Phase 3, Atopic Dermatitis) |
| Takeda Pharmaceutical Company | TAK | 2 | IBI363 (Phase 3, Non-Small Cell Lung Cancer, Colorectal Cancer); Mezagitamab (Phase 3, Chronic Kidney Disease, IgA Nephropathy) |
| TJ Biopharma Co., Ltd. | — | 2 | Efmedaglutide alfa (Phase 3, Obesity, Type 2 Diabetes); Uliledlimab (Phase 2/3, Non-Small Cell Lung Cancer) |
| 3D Medicines Inc. | 1244 | 1 | Envafolimab (Phase 3, HIV, Non-Small Cell Lung Cancer, Chronic Hepatitis B and more) |
| 89bio | — | 1 | Pegozafermin (Phase 3, MASH / NASH, Severe Hypertriglyceridemia) |
| Abbott | ABT | 1 | Serplulimab (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Gastric Cancer) |
| Accord Healthcare | — | 1 | Serplulimab (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Gastric Cancer) |
| Actinium Pharmaceuticals | ATNM | 1 | 131I-apamistamab (Phase 3, Acute Myeloid Leukemia) |
| Aeira Pte. Ltd. | — | 1 | stapokibart (Phase 3, Atopic Dermatitis, Chronic Obstructive Pulmonary Disease, Asthma and more) |
| Agenus Inc. | AGEN | 1 | Botensilimab (Phase 3, Non-Small Cell Lung Cancer, Colorectal Cancer) |
| AnaptysBio | ANAB | 1 | Imsidolimab (Phase 3, Psoriasis) |
| Ascletis Pharma | 1672 | 1 | Envafolimab (Phase 3, HIV, Non-Small Cell Lung Cancer, Chronic Hepatitis B and more) |
| Ashibio Inc | — | 1 | Andecaliximab (Phase 2/3, Fibrodysplasia Ossificans Progressiva) |
| Astellas Pharma | 4503 | 1 | ASP2138 (Phase 3, Gastric Cancer) |
| Beijing Dongfang Biotech | — | 1 | exendin-4 Fc fusion (JY09) (Phase 3, Type 2 Diabetes) |
| Beijing Mabworks Biotech Co., Ltd. | — | 1 | Obinutuzumab beta (Bejescin) (Phase 3, Systemic Lupus Erythematosus, Follicular Lymphoma, Primary Membranous Nephropathy) |
| Beijing Xinkanghe Biomedical Technology Co., Ltd. | — | 1 | Lecankitug (Phase 3, Psoriasis) |
| BeOne Medicines | ONC | 1 | BGB-B2033 (Phase 3, Non-Small Cell Lung Cancer, Hepatocellular Carcinoma) |
| Biotest AG | — | 1 | Human hepatitis B Immunoglobulin (Hepatect®CP/Zutectra®) (Phase 3) |
| Bluefin Biomedicine | — | 1 | BFB759 (Phase 2/3, Atopic Dermatitis, Hidradenitis Suppurativa) |
| Boehringer Ingelheim | — | 1 | Obrixtamig (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer) |
| Brii Biosciences | 2137 | 1 | Tobevibart (VIR-3434) (Phase 3, Chronic Hepatitis Delta) |
| Celldex Therapeutics | CLDX | 1 | barzolvolimab (Phase 3, Atopic Dermatitis, Chronic Spontaneous Urticaria, Chronic Inducible Urticaria) |
| Changchun GeneScience Pharmaceutical | — | 1 | Somatropin (Jintropin) (Phase 3, Chronic Kidney Disease) |
| Chong Kun Dang Pharmaceutical | 185750 | 1 | CKD-701 (Phase 3, Age-Related Macular Degeneration) |
| Compass Therapeutics | CMPX | 1 | tovecimig (Phase 2/3, Biliary Tract Cancer) |
| COMPUGEN LTD | CGEN | 1 | Rilvegostomig (Phase 3, Non-Small Cell Lung Cancer, Hepatocellular Carcinoma, Biliary Tract Cancer and more) |
| Conjupro Biotherapeutics, Inc. | — | 1 | CPO301 (Phase 3, Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Breast Cancer) |
| Connect Biopharma | CNTB | 1 | Rademikibart (Phase 3, Atopic Dermatitis, Chronic Obstructive Pulmonary Disease, Asthma) |
| Corbus Pharmaceuticals | CRBP | 1 | Sutantatug envedotin (Phase 3, Cervical Cancer, Urothelial Carcinoma) |
| CSPC Megalith Biopharmaceutical | — | 1 | Sutantatug envedotin (Phase 3, Cervical Cancer, Urothelial Carcinoma) |
| CStone Pharmaceuticals | 2616 | 1 | Sugemalimab (Phase 3, Non-Small Cell Lung Cancer) |
| Cullinan Therapeutics Inc. | CGEM | 1 | Velinotamig (GR1803) (Phase 3, Multiple Myeloma) |
| CytoDyn | CYDY | 1 | Leronlimab (Phase 2/3, Alzheimer's Disease, HIV, Metastatic Colorectal Cancer) |
| DiaMedica Therapeutics | DMAC | 1 | Rinvecalinase alfa (Phase 2/3, Acute Ischemic Stroke) |
| Dr. Reddy's Laboratories | RDY | 1 | HLX15 (Phase 3, Multiple Myeloma) |
| Elevar Therapeutics, Inc. | — | 1 | Camrelizumab (Phase 3, Non-Small Cell Lung Cancer, Cervical Cancer, Hepatocellular Carcinoma and more) |
| Elpiscience (Suzhou) Biopharma, Ltd. | — | 1 | Ordastobart (Phase 2/3, Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma) |
| Essex Bio-Technology Limited | 1061 | 1 | HLX04-O (Phase 3, Age-Related Macular Degeneration) |
| Ewopharma | — | 1 | Sugemalimab (Phase 3, Non-Small Cell Lung Cancer) |
| Fosun Wanbang Pharma Group | — | 1 | Roconkibart (Phase 3, Psoriasis) |
| Genmab | GMAB | 1 | Rinatabart sesutecan (Rina-S) (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Ovarian Cancer and more) |
| Grifols | GRF | 1 | Human hepatitis B Immunoglobulin (Hepatect®CP/Zutectra®) (Phase 3) |
| HanAll BioPharma | 009420 | 1 | Imeroprubart (Phase 3, Rheumatoid Arthritis, Myasthenia Gravis, Graves' Disease and more) |
| Hansa Biopharma | HNSA | 1 | Imlifidase (Phase 3, Chronic Kidney Disease) |
| Harbour BioMed | 2142 | 1 | WIN378 (Phase 2/3, Chronic Obstructive Pulmonary Disease, Asthma) |
| Huahui Health | — | 1 | Libevitug (HH-003) (Phase 3, Chronic Hepatitis B, Chronic Hepatitis Delta) |
| Hubei Jumpcan Pharmaceutical | 600566 | 1 | Ebronucimab (Phase 3, Atherosclerotic Cardiovascular Disease, Mixed Hyperlipidemia) |
| Immunocore Holdings plc | IMCR | 1 | brenetafusp (Phase 3, Cutaneous Melanoma) |
| Immunovant, Inc. | IMVT | 1 | Imeroprubart (Phase 3, Rheumatoid Arthritis, Myasthenia Gravis, Graves' Disease and more) |
| Inhibrx Biosciences, Inc | INBX | 1 | Ordastobart (Phase 2/3, Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma) |
| Innate Pharma | IPH | 1 | Monalizumab (Phase 3, Non-Small Cell Lung Cancer) |
| Istituto Gentili S.R.L. | — | 1 | Sugemalimab (Phase 3, Non-Small Cell Lung Cancer) |
| Jade Biosciences, Inc. | JBIO | 1 | JADE101 (Phase 3, IgA Nephropathy) |
| JCR Pharmaceuticals | 4552 | 1 | JR-131 (Phase 3, Chronic Kidney Disease) |
| Jiangsu Genscend Biopharmaceutical | — | 1 | GS101 (Phase 3, Atopic Dermatitis) |
| Kalbe Genexine Biologics | — | 1 | Serplulimab (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Gastric Cancer) |
| Kissei Pharmaceutical | 4547 | 1 | JR-131 (Phase 3, Chronic Kidney Disease) |
| Laboratorios Stein S.A. | — | 1 | Sugemalimab (Phase 3, Non-Small Cell Lung Cancer) |
| Lakefront Biotherapeutics NV | LKFT | 1 | Gamgertamig (CM336) (Phase 3, Multiple Myeloma) |
| LIB Therapeutics | — | 1 | Lerodalcibep (Phase 3, Atherosclerotic Cardiovascular Disease) |
| Livzon Pharmaceutical Group Inc. | 000513 | 1 | Lecankitug (Phase 3, Psoriasis) |
| Lotus Pharmaceutical Co., Ltd. | — | 1 | Serplulimab (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Gastric Cancer) |
| Luye Pharma Group | 2186 | 1 | LY01008 (Phase 3, Non-Small Cell Lung Cancer, Colorectal Cancer) |
| mAbxience Research S.L. | — | 1 | MB12 (Phase 3, Non-Small Cell Lung Cancer) |
| Merck KGaA | MKKGY | 1 | precemtabart tocentecan (Phase 3, Non-Small Cell Lung Cancer, Metastatic Colorectal Cancer) |
| Mereo BioPharma | MREO | 1 | setrusumab (Phase 3, Osteogenesis Imperfecta) |
| Merz Pharmaceuticals | — | 1 | IncobotulinumtoxinA (Xeomin) (Phase 3, Parkinson's Disease, Migraine) |
| MoonLake Immunotherapeutics | MLTX | 1 | sonelokimab (Phase 3, Psoriatic Arthritis, Psoriasis, Hidradenitis Suppurativa) |
| Multitude Therapeutics Inc. | — | 1 | AMT-116 (Phase 2/3, Non-Small Cell Lung Cancer) |
| Nanogen Pharmaceutical Biotechnology | — | 1 | NNG-DEPO (Phase 3, Chronic Kidney Disease) |
| Nektar Therapeutics | NKTR | 1 | rezpegaldesleukin (Phase 3, Atopic Dermatitis, Alopecia Areata) |
| Norgine | — | 1 | Tobevibart (VIR-3434) (Phase 3, Chronic Hepatitis Delta) |
| NovaBridge Biosciences | NBP | 1 | Uliledlimab (Phase 2/3, Non-Small Cell Lung Cancer) |
| OncoC4, Inc. | — | 1 | Gotistobart (Phase 3, Non-Small Cell Lung Cancer) |
| Polaris Group | 6550 | 1 | Pegargiminase (Phase 3, Acute Myeloid Leukemia, Hepatocellular Carcinoma) |
| Prestige Biopharma Limited | 950210 | 1 | HD204 (Phase 3, Non-Small Cell Lung Cancer) |
| Prothena Biosciences Limited | PRTA | 1 | Prasinezumab (Phase 3, Parkinson's Disease) |
| Pyxis Oncology | PYXS | 1 | MW02 (Phase 2/3, Age-Related Macular Degeneration) |
| Qyuns Therapeutics | 2509 | 1 | HS-20137 (Phase 3, Psoriasis) |
| Roivant Sciences Ltd. | ROIV | 1 | Imeroprubart (Phase 3, Rheumatoid Arthritis, Myasthenia Gravis, Graves' Disease and more) |
| Santen Pharmaceutical Co., Ltd. | 4536 | 1 | RC28-E (Phase 3, Age-Related Macular Degeneration, Diabetic Macular Edema) |
| Savara Inc. | SVRA | 1 | molgramostim (Phase 3, Autoimmune Pulmonary Alveolar Proteinosis) |
| Shandong New Time Pharmaceutical Co., Ltd. | — | 1 | F182112 (Phase 3, Multiple Myeloma) |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 600196 | 1 | Velinotamig (GR1803) (Phase 3, Multiple Myeloma) |
| Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 600196 | 1 | Serplulimab (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Gastric Cancer) |
| Shanghai Huaota Biopharmaceutical Co. | — | 1 | HB0034 (Phase 2/3, Psoriasis) |
| Shanghai Yinnuo Pharmaceutical Technology | — | 1 | efsubaglutide alfa (Phase 3, Obesity, Type 2 Diabetes) |
| Shenzhen Salubris Pharmaceuticals | 002294 | 1 | SAL003 (Phase 3, Atherosclerotic Cardiovascular Disease) |
| Sino Biopharmaceutical | 1177 | 1 | TQB2934 (Phase 3, Multiple Myeloma) |
| STADA Arzneimittel | — | 1 | Ranibizumab (Ximluci) (Phase 3, Age-Related Macular Degeneration) |
| Summit Therapeutics | SMMT | 1 | Ivonescimab (Phase 3, Non-Small Cell Lung Cancer, Biliary Tract Cancer, Metastatic Colorectal Cancer) |
| Sun Pharmaceutical Industries | SUNPHARMA | 1 | Lerodalcibep (Phase 3, Atherosclerotic Cardiovascular Disease) |
| Suzhou Alphamab | — | 1 | Envafolimab (Phase 3, HIV, Non-Small Cell Lung Cancer, Chronic Hepatitis B and more) |
| Suzhou Zelgen Biopharmaceuticals | 688266 | 1 | Nilvanstomig (Phase 3, Non-Small Cell Lung Cancer, Hepatocellular Carcinoma) |
| SystImmune | — | 1 | BL-M11D1 (Phase 2/3, Acute Myeloid Leukemia) |
| Teva Pharmaceutical Industries | TEVA | 1 | duvakitug (Phase 3, Ulcerative Colitis, Crohn's Disease, Hidradenitis Suppurativa) |
| Timberlyne Therapeutics | — | 1 | Lumrotatug (Phase 3, Multiple Myeloma) |
| Ultragenyx Pharmaceutical Inc. | RARE | 1 | setrusumab (Phase 3, Osteogenesis Imperfecta) |
| United BioPharma | — | 1 | Semzuvolimab (Phase 3, HIV) |
| Vanda Pharmaceuticals | VNDA | 1 | Imsidolimab (Phase 3, Psoriasis) |
| Vertex Pharmaceuticals | VRTX | 1 | Povetacicept (Phase 3, Myasthenia Gravis, IgA Nephropathy, Primary Membranous Nephropathy) |
| Vir Biotechnology | VIR | 1 | Tobevibart (VIR-3434) (Phase 3, Chronic Hepatitis Delta) |
| Vor Bio | VOR | 1 | Telitacicept (Phase 3, Rheumatoid Arthritis, IgA Nephropathy, Sjögren's Disease and more) |
| Windward Bio | — | 1 | WIN378 (Phase 2/3, Chronic Obstructive Pulmonary Disease, Asthma) |
| Xbrane Biopharma AB | XBRANE | 1 | Ranibizumab (Ximluci) (Phase 3, Age-Related Macular Degeneration) |
| Zenas BioPharma | ZBIO | 1 | Obexelimab (Phase 3, Systemic Lupus Erythematosus, IgG4-Related Disease) |
| Zensun (Shanghai) Sci & Tech | — | 1 | Recombinant human neuregulin-1 (rhNRG-1) (Phase 3, Heart Failure) |
| Zhejiang Doer Biologics | — | 1 | DR10624 (Phase 3, Obesity, Severe Hypertriglyceridemia) |
| Zydus Lifesciences | ZYDUSLIFE | 1 | Botensilimab (Phase 3, Non-Small Cell Lung Cancer, Colorectal Cancer) |
Stage is the furthest stage the drug has reached in any indication. Kind follows each drug's recorded modality; a drug whose modality is not recorded is left out.